JP Morgan Chase
AGL icon

JP Morgan Chase’s Agilon Health AGL Stock Holding History

JP Morgan Chase’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.22K Buy
28,690
+9,012
+46% +$146K ﹤0.01% 6761
2025
Q4 		$339K Sell
19,678
-64,534
-77% -$1.25M ﹤0.01% 5260
2025
Q3 		$2.17M Buy
84,212
+57,002
+209% +$2.15M ﹤0.01% 4019
2025
Q2 		$1.56M Sell
27,210
-38,169
-58% -$3.06M ﹤0.01% 4093
2025
Q1 		$7.08M Buy
65,379
+55,405
+555% +$4.82M ﹤0.01% 2859
2024
Q4 		$474K Sell
9,974
-46,643
-82% -$2.82M ﹤0.01% 5073
2024
Q3 		$5.56M Buy
56,617
+37,484
+196% +$4.84M ﹤0.01% 3137
2024
Q2 		$3.13M Buy
19,133
+65
+0.3% +$9.26K ﹤0.01% 3406
2024
Q1 		$2.91M Buy
19,068
+8,344
+78% +$1.39M ﹤0.01% 3538
2023
Q4 		$3.36M Buy
10,724
+3,265
+44% +$1.18M ﹤0.01% 3430
2023
Q3 		$3.31M Buy
7,459
+3,344
+81% +$1.51M ﹤0.01% 3146
2023
Q2 		$1.78M Sell
4,115
-129
-3% -$72.5K ﹤0.01% 3621
2023
Q1 		$2.52M Buy
4,244
+213
+5% +$119K ﹤0.01% 3372
2022
Q4 		$1.63M Buy
4,031
+242
+6% +$113K ﹤0.01% 3717
2022
Q3 		$2.22M Buy
3,789
+510
+16% +$305K ﹤0.01% 3385
2022
Q2 		$1.79M Sell
3,279
-7,047
-68% -$3.56M ﹤0.01% 3640
2022
Q1 		$6.54M Buy
10,326
+9,976
+2,850% +$5.14M ﹤0.01% 2772
2021
Q4 		$237K Buy
350
+32
+10% +$19.5K ﹤0.01% 5254
2021
Q3 		$208K Buy
318
+67
+27% +$57.2K ﹤0.01% 5212
2021
Q2 		$255K Buy
+251
New +$220K ﹤0.01% 5101

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

JP Morgan Chase's AGL Position: Q1 2026 in Review

JP Morgan Chase increased its Agilon Health (AGL) stake by 46% in Q1 2026, buying an estimated $146K and bringing the position to 28,690 shares worth $9.22K. The position accounts for ﹤0.01% of the portfolio, ranked #6761.

JP Morgan Chase first reported a position in AGL in Q2 2021 and has held it in 20 quarters since. The position peaked at $7.08M in Q1 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • JP Morgan Chase held 28,690 shares of Agilon Health worth $9.22K as of Q1 2026.
  • JP Morgan Chase bought 9,012 Agilon Health shares in Q1 2026, an estimated $146K.
  • Agilon Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6761 holding.
  • JP Morgan Chase first reported a position in Agilon Health in Q2 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's Agilon Health position peaked at $7.08M in Q1 2025.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.